Inventor · disambiguated record
Arvinder Dhalla
Also filed as: DHALLA ARVINDER
4 granted patents·9 pending applications·31 citations·filing 2003–2020
74Inventor score
Files withCV THERAPEUTICS INC4DHALLA ARVINDER3BELARDINELLI LUIZ2GILEAD SCIENCES INC2GILEAD PALO ALTO INC1
Top patents by PatentIndex Score
13 records- 0188US7713946B2Partial and full agonists A1 adenosine receptorsCV THERAPEUTICS INC·Filed 2006·Granted May 11, 2010·12 cites·19 claims
- 0287US7479485B2Method of treating arrhythmiasCV THERAPEUTICS INC·Filed 2005·Granted Jan 20, 2009·5 cites·5 claims
- 0381US7005425B2Method for treating arrhythmiasCV THERAPEUTICS INC·Filed 2003·Granted Feb 28, 2006·14 cites·18 claims
- 0471US2009118221A1Method of treating arrhythmiasBELARDINELLI LUIZ·Filed 2009·Application pending·0 cites
- 0562US2009247557A1Partial and full agonists of a1 adenosine receptorsDHALLA ARVINDER·Filed 2009·Application pending·0 cites
- 0656US2007299089A1Use of A2A Adenosine Receptor Agonists in the Treatment of IschemiaCV THERAPEUTICS INC·Filed 2007·Application pending·0 cites
- 0754US2008255031A1Method for enhancing insulin secretionDHALLA ARVINDER·Filed 2008·Application pending·0 cites
- 0848US7939509B2Partial and full agonists of A1 adenosine receptorsGILEAD SCIENCES INC·Filed 2010·Granted May 10, 2011·0 cites·13 claims
- 0947US2020289620A1Therapeutic agent preparations and methods for drug delivery into a lumen of the intestinal tract using a swallowable drug delivery deviceRANI THERAPEUTICS LLC·Filed 2020·Application pending·0 cites
- 1047US2014221286A1Sodium channel blockers reduce glucagon secretionGILEAD SCIENCES INC·Filed 2012·Application pending·0 cites
- 1146US2009203689A1Abca-1 elevating compounds and methodsDHALLA ARVINDER·Filed 2009·Application pending·0 cites
- 1242US2008153840A1Reduction of cardiovascular symptomsBELARDINELLI LUIZ·Filed 2007·Application pending·0 cites
- 1341US2010105695A1Method for enhancing insulin secretionGILEAD PALO ALTO INC·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →